Friday, February 10, 2017

"The 72 cancer therapies approved from 2002 to 2014 gave patients only 2.1 more months of life than older drugs"

USAT:

And those are the successes.

...

Cancer drugs approved last year cost an average of $171,000 a year

...

Recognizing the slow pace of progress, the American Society of Clinical Oncology has set goals for new cancer drugs of extending life or controlling tumors for at least 2.5 months.